PD-L1 in T cells, APCs, and host tissues, rather than cancer cell-intrinsic PD-L1, may play a critical role in suppressing antitumor immunity, as limiting T cell trafficking reduces the efficacy of blockade (Juneja et al., 2017; Tang et al., 2018; Lin et al., 2018). The gene discussed is CD274; the disease is cancer.